Page 60 - Read Online

Page 170 Elton et al. Cancer Drug Resist 2020;3:161-70 I http://dx.doi.org/10.20517/cdr.2019.117

bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res 1995;55:2129-34.
55. Ritke MK, Yalowich JC. Altered gene expression in human leukemia K562 cells selected for resistance to etoposide. Biochem
Pharmacol 1993;46:2007-20.
56. Ritke MK, Roberts D, Allan WP, Raymond J, Bergoltz VV, et al. Altered stability of etoposide-induced topoisomerase Il-DNA
complexes in resistant human leukemia K562 cells. Br J Cancer 1994;69:687-97.
57. Zwelling LA, Hinds M, Chan D, Mayes J, Sie KL, et al. Characterization of an amsacrine-resistant line of human leukemia cells.
Evidence for a drug-resistant form of topoisomerase II. J Biol Chem 1989;264:16411-20.
58. Christie M, Chang CW, Róna G, Smith KM, Stewart AG, et al. Structural biology and regulation of protein import into the nucleus. J
Mol Biol 2016;428:2060-90.
59. Gardiner LP, Roper DI, Hammonds TR, Maxwell A. The N-terminal domain of human topoisomerase II alpha is a DNA-dependent
ATPase. Biochemistry 1998;37:16997-7004.
60. Campbell S, Maxwell A. The ATP-operated clamp of human DNA topoisomerase II alpha: hyperstimulation of ATPase by “piggy-back”
binding. J Mol Biol 2002;320:171-88.
61. Hu T, Sage H, Hsieh TS. ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug
bisdioxopiperazine and ATP/ADP-induced dimerization. J Biol Chem 2002;277:5944-51.
62. Austin CA, Lee KC, Swan RL, Khazeem MM, Manville CM, et al. TOP2B: the first thirty years. Int J Mol Sci 2018;19. E2765.
63. Cowell IG, Austin CA. Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related
leukemia? Cell Cycle 2012;11:3143-4.
64. Cowell IG, Sondka Z, Smith K, Lee KC, Manville CM, et al. Model for MLL translocations in therapy-related leukemia involving
topoisomerase IIβ-mediated DNA strand breaks and gene proximity. Proc Natl Acad Sci U S A 2012;109:8989-94.